mynth
06/2026100%

Padoa acquired by Thoma Bravo

FRANCE Software / Industry-Specific Software / Healthcare EV €500M–1.5bn

Context

Five Arrows has sold Padoa to US-based Thoma Bravo in a landmark leveraged buyout (LBO) aimed at supporting the company's next phase of growth. This transaction marks a significant milestone in Padoa's evolution, as the company comes under the control of a specialized investor in B2B software and technology, renowned for its expertise in backing accelerating software publishers. The deal, which was highly contested among international investors, reflects the attractiveness of the healthcare software sector and the high quality of the asset. The selected buyer stands out for its investment strategy focused on software publishers, combining operational optimization and accelerated organic and inorganic growth. Beyond the change in ownership, the goal is to support Padoa's expansion in its domestic and international markets, driven by the increasing digitalization of occupational health services. The financial structure is based on a combination of senior debt and subordinated instruments, providing the necessary flexibility to support the company's future development. Ultimately, this transaction is part of a broader consolidation trend in the healthcare software sector, aimed at creating leading players in a rapidly evolving market.

The acquisition of Padoa is part of the growth strategy of Thoma Bravo, which already has several external growth operations under its belt, notably Verint Systems in 2025.

Padoa, which reported an EBITDA margin of [members only] in 2026, is valued in this transaction at an EV/EBITDA multiple of 15x–25x.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Padoa is a French company specializing in the development of software solutions for occupational health. Founded in 2016 in Paris, the company has built a SaaS platform designed to digitize and streamline the activities of intercompany occupational health and prevention services (SPSTI). The solution aims to centralize medical and administrative data, facilitate employee monitoring pathways, and enhance coordination among various stakeholders in the occupational health sector. The company has developed an integrated technological approach, combining medical record management, visit scheduling, occupational risk tracking, and performance management tools for healthcare professionals. Padoa primarily targets a regulated and recurring market characterized by structural digitalization and compliance needs. This positioning enables the company to benefit from a subscription-based business model with a high revenue recurrence rate. As a result, Padoa has established itself as a reference player in its segment in France, driven by the growing adoption of its platform by occupational health services. The company's development has been supported by several specialized venture capital and private equity investors, allowing it to accelerate its product deployment and commercial expansion. Padoa operates at the intersection of the healthcare and SaaS technology sectors, with a strong regulatory component and a client base comprising institutional entities.

Ent. Value

€500M–1.5bn

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2026
[members only]
€10–30M
[members only]
2025
[members only]
€10–30M
[members only]

Other operations with Thoma Bravo

Other operations with Thoma Bravo
DateAcquirerTargetCountrySector
10/2026THOMA BRAVOVARONIS SYSTEMSUNITED STATESCybersecurity Services
08/2026THOMA BRAVOACCELERANTUNITED STATESInsurance
08/2025THOMA BRAVOVERINT SYSTEMSUNITED STATESCRM & Sales
01/2019THOMA BRAVOIMPERVAUNITED STATESCybersecurity Services
10/2018THOMA BRAVOVERACODEUNITED STATESSoftware
11/2017THOMA BRAVOBARRACUDA NETWORKSUNITED STATESCybersecurity Services

Similar deals in Software

Similar deals in Software
DateAcquirerTargetCountrySector
07/2026BOWMARKSFG20UNITED KINGDOMConstruction / Real Estate
07/2026BRIDGEPOINTSKELLOFRANCEERP, HR & Finance
06/2026CVCCHESS.COMUNITED STATESGaming & Consumer Apps
06/2026WALMARTVIBEUNITED STATESAdTech
06/2026SCHNEIDER ELECTRICCOGNITENETHERLANDSData, Analytics & AI
06/2026PERMIRA / WARBURG PINCUSCLEARWATER ANALYTICSUNITED STATESFinancial Services / Banking
06/2026VEEVA SYSTEMSCOPLIDENMARKHealthcare
06/2026EOS PARTNERSDROOMSGERMANYCollaboration & Productivity
06/2026ASYSM-WORKFRANCECollaboration & Productivity
06/2026MONTAGU PRIVATE EQUITYBMC HELIXUNITED STATESData, Analytics & AI

REFERENCES

Valuation range: EV €500M–1.5bn

EBITDA range: €10–30M

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Padoa by Thoma Bravo are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: padoa

FAQ

What transaction does this page cover?

This page covers Thoma Bravo’s acquisition of 100% of Padoa, a French company specialised in Industry-Specific Software, in 2026.

How was the acquisition of Padoa by Thoma Bravo valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €500M–1.5bn band and its EV/EBITDA multiple within the 15x - 25x range. Exact figures are available to members.

What was Padoa’s EBITDA at the time of the deal?

At the time of the transaction, Padoa’s EBITDA was estimated within the €10–30M bracket (FY 2026). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.